Cost-Effectiveness Of Rivaroxaban Compared With Combined Low Molecular Weight Heparin/Vitamin K Antagonist For The Treatment Of Pulmonary Embolism In China
Abstract
Authors
Y Feng L Yang J Wu
Y Feng L Yang J Wu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now